Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-76 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418 |
filingDate |
2005-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05dd7d29d19faa8b77b377b660edecec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e698493b7081e0866d522a049b201ae9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08aa9a0ba83c3b64e64d5fb66a7eaaad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_589e637640a348954dfd7929f1080661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fc65e55e9aaa25a773e5aaa832e3e64 |
publicationDate |
2009-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7528159-B2 |
titleOfInvention |
5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes |
abstract |
Compounds of formula (I): n nas well as pharmaceutically acceptable salts and esters thereof used in the form of pharmaceutical compositions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009149503-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8211913-B2 |
priorityDate |
2004-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |